Dilshad Akif, Salim Adnan, Haq Muhammad Israr Ul, Amin Johar, Malik Kashif, Alam Altaf
Department of Gastroenterology and Hepatology, Shaikh Zayed Hospital, Lahore.
J Coll Physicians Surg Pak. 2018 Jul;28(7):514-517. doi: 10.29271/jcpsp.2018.07.514.
To evaluate the therapeutic efficacy of endoscopic dilatation of anastomotic stricture (AS).
An observational study.
Department of Gastroenterology and Hepatology, Shaikh Zayed Hospital, Lahore, Pakistan from November 2016 to November 2017.
Patients presenting with anastomotic biliary stricture following living donor liver transplant (LDLT) underwent endoscopic retrograde cholangio-pancreaticography (ERCP) and treatment of their strictures with dilatation with or without stenting. The patients were then followed up to see adequate resolution of stricture and repeat therapeutic ERCP was performed, if required. The patients were labelled as cured if stricture resolution persisted for a period of up to six months following ERCP.
Forty-three patients (32 males and 11 females), with post-LDLT AS, who met the inclusion and exclusion criteria were enrolled in the study. Thirty-six (83.7%) patients had a single biliary anastomosis while seven (16.3%) patients had two anastomoses. Ductoplasty was done in 15 (34.9%) of the enrolled patients. Patients with post-LDLT AS required 3.65 +1.15 sessions of ERCP. Plastic type biliary stent was used in seven (16.3%) patients, balloon dilatation alone was done in five (11.6%) patients and combined balloon dilatation and stent placement was performed in 29 (67.4%) patients, and combined graduated dilator and stent placement was performed in two (4.7%) patients. Five (11.6%) patients required rendezvous procedure (whereby a radiologist placed a guidewire percutaneously into the biliary system) as guidewire placement across stricture site was endoscopically unsuccessful. The overall success rate was 88.4%. Mean stent free follow-up was 7.18 +1.38 months. Recurrence of AS was noted in one (2.3%) patient.
Endoscopic management of post-LDLT AS has an efficacious long-term outcome.
评估内镜下扩张吻合口狭窄(AS)的治疗效果。
一项观察性研究。
2016年11月至2017年11月于巴基斯坦拉合尔谢赫扎耶德医院胃肠病与肝病科。
活体供肝肝移植(LDLT)术后出现吻合口胆管狭窄的患者接受内镜逆行胰胆管造影(ERCP),并采用扩张术(伴或不伴支架置入)治疗其狭窄。随后对患者进行随访,观察狭窄是否充分缓解,必要时重复进行治疗性ERCP。若ERCP后狭窄缓解持续长达6个月,则将患者标记为治愈。
43例符合纳入及排除标准的LDLT术后AS患者纳入本研究。其中36例(83.7%)患者有单一胆管吻合口,7例(16.3%)患者有两个吻合口。15例(34.9%)入组患者进行了胆管成形术。LDLT术后AS患者需要3.65±1.15次ERCP治疗。7例(16.3%)患者使用了塑料型胆管支架,5例(11.6%)患者仅行球囊扩张,29例(67.4%)患者行球囊扩张联合支架置入,2例(4.7%)患者行联合渐进式扩张器及支架置入。5例(11.6%)患者因内镜下无法在狭窄部位成功置入导丝而需要会师操作(由放射科医生经皮将导丝置入胆管系统)。总体成功率为88.4%。支架取出后的平均随访时间为7.18±1.38个月。1例(2.3%)患者出现AS复发。
LDLT术后AS的内镜治疗具有有效的长期疗效。